Halifax, John C.
Lim, Lilly
Ciccarone, Daniel
Lynch, Kara L.
Funding for this research was provided by:
National Institutes of Health (DA037820)
National Institute on Drug Abuse (DA054190)
Article History
Received: 21 April 2023
Accepted: 26 December 2023
First Online: 18 January 2024
Declarations
:
: Not applicable.
: Not applicable.
: JH, LL, and KL have nothing to disclose and no conflicts of interest declared. DC is a scientific advisor to Celero Systems and is retained as an expert by Motley-Rice LLC in ongoing opioid litigation. His effort on this project was supported by NIH/NIDA grants DA037820 and DA054190.